Glurenorm

Glurenorm is a prescription oral medication that contains the active ingredient gliquidone, a sulfonylurea class drug used for managing blood glucose. It is formulated for oral administration and is marketed within the European Union. As an oral hypoglycemic agent, Glurenorm works by stimulating insulin release from pancreatic beta cells, helping to control hyperglycemia in adults with type 2 diabetes mellitus.

Glurenorm is indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient. It may be used as monotherapy or in combination with other antidiabetic agents.

- Improves glycemic control in adults with type 2 diabetes. - Can be combined with metformin or thiazolidinediones when additional glucose lowering is needed. - May be considered when other sulfonylureas are not suitable. - Used as part of a comprehensive diabetes management plan including diet and exercise. - Prescribed when oral therapy is preferred over insulin initiation.

Glurenorm may cause a range of side effects, some of which are more frequently observed while others are rare but serious.

Common: - Mild hypoglycemia, especially if meals are missed. - Nausea or gastrointestinal discomfort. - Headache or dizziness. - Weight gain due to increased insulin activity. - Skin rash or mild itching.

Serious: - Severe hypoglycemia leading to loss of consciousness. - Allergic reactions such as swelling of the face, lips, or throat. - Hepatotoxicity presenting as jaundice or elevated liver enzymes. - Hematologic abnormalities like leukopenia or thrombocytopenia. - Pancreatitis with abdominal pain and elevated enzymes.

Before starting Glurenorm, certain health considerations should be reviewed to ensure safe use.

- Assess renal and hepatic function, as impairment may affect drug clearance. - Caution in patients with a history of cardiovascular disease or arrhythmias. - Monitor blood glucose regularly to detect hypoglycemia early. - Use with care during pregnancy or breastfeeding; consult a healthcare professional. - Adjust dosage in elderly patients due to increased sensitivity. - Avoid abrupt discontinuation to prevent rebound hyperglycemia.

Glurenorm can interact with several medications, influencing its efficacy or safety profile.

Avoid: - Concurrent use with other sulfonylureas or insulin secretagogues, which may increase hypoglycemia risk. - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that can raise gliquidone plasma levels. - High‑dose aspirin or NSAIDs that may potentiate hypoglycemic effects.

Use with caution: - Beta‑blockers, which can mask hypoglycemia symptoms. - Thiazide diuretics, as they may affect glucose metabolism. - Anticoagulants, because altered glycemic control can influence INR. - Oral contraceptives, which may modify drug metabolism. - Alcohol, which can potentiate hypoglycemia, especially with missed meals.